Pharmaceutical Industry Reports Immune Repertoire Sequencing Market | Page 2

REPORT DESCRIPTION
Immune Repertoire Sequencing Market – Overview
Immune repertoire refers to the sub-type proteins an organism’s immune system creates. Immune systems in
vertebrates have six key types of proteins namely: immunoglobulin (2) and T cell receptors (4). Immune repertoire
sequencing enables researchers and scientist to examine and understand adaptive immune-mediated diseases.
Immune repertoire sequencing is also widely applicable in biomarker discovery, infectious disease research, asthma
and allergy research, and cancer immunotherapy.
Increasing research and development and launches of novel products by key players in market is expected to be the
major driving force for growth of global immune repertoire sequencing market in the near future. For instance, in
2016, ArcherDX, Inc., a U.S.-based company, expanded its product portfolio with the launch of its latest Archer
Immunoverse immune repertoire sequencing assays at the American Society of Hematology (ASH). In 2017,
ArcherDX, Inc. launched its latest Archer Immunoverse B Cell Receptor (BCR) assays to characterize the human B
cell repertoire. In 2017, researchers from Stanford University applied immune repertoire sequencing to identify
disease-related signatures in the immune systems of patients with systemic sclerosis with pulmonary hypertension
(SSc-PAH), a rare chronic autoimmune disease that affects the connective tissue. Increasing research on immune
repertoire sequencing is expected to create a conducive environment for growth of immune repertoire sequencing
market in the near future.
© Coherent market Insights. All Rights Reserved